KOGAS and Bp Sign Long-term US LNG Supply Agreement
According to World Gas News on April 23, Korea Gas Corporation (KOGAS) signed a long-term contract with British oil and gas company bp to purchase U.S. liquefied natural gas.
The agreement is an 18-year Henry Hub LNG sales and purchase agreement. KOGAS said it hopes to contribute to the stabilization of domestic natural gas prices.
Under the SPA agreement, BP Singapore will deliver 1.58 million tonnes of LNG annually to South Korea starting in 2025. This is equivalent to about 3% of annual domestic consumption. The LNG will come from the United States, including Freeport LNG.
The contract is the result of an international liquefied natural gas (LNG) tender conducted by KOGAS in 2018 to secure competitive liquefied natural gas (LNG) volumes. In addition, it signed a 20-year agreement with Qatar from July 2021 to purchase 2 million tonnes of LNG per year.
In addition, this is the first long-term contract between KOGAS and bp, which is a catalyst to strengthen the cooperation between the two companies.
Earlier this month, the South Korean company also reached an agreement with U.S. energy company Sempra Infrastructure to jointly realize the global low-carbon, zero-carbon energy transition.
2026-10-25
Trade Alert
Delivering the latest product trends and industry news straight to your inbox.
(We'll never share your email address with a third-party.)
Related News
-
Pregabalin vs Gabapentin: Differences, Uses, and Side Effects
-
Lotte Merges with HD Hyundai: Can Korea’s Petrochemical First Case Trigger True Restructuring?
-
Türkiye Advances $3 Billion Petrochemical Cluster Targeting 17% of Domestic Polypropylene Demand
-
Dow Swings from an $801 Million Loss to an $802 Million Profit as Hormuz Disruption Lifts Polyethylene Prices
-
Argentina to Build Latin America’s Largest Urea Plant Under €1.3 Billion Contract
-
After Two Price Hikes in One Week, Dow Has Fully Exposed the Most Sensitive Nerve in Europe’s Polyurethane Market
-
Yulong Petrochemical’s 100,000-ton MMA Project Comes Online Amid a “Deep V-Shaped Rebound” — Opportunity or Hidden Risk?
-
BASF Battles Market Turmoil as Profits Slide
-
Pfizer Sues Metsera and Novo Nordisk Over Rival Obesity Drug Strategy
-
Cipla CEO Calls Tirzepatide a High-Science Product with Strong Market Outlook
Recommend Reading
-
Pfizer Seen Holding Strategic Edge in Bidding Battle for Metsera
-
Novo Nordisk Enters High-Stakes Bidding War with Pfizer for Metsera
-
Merck and Eisai Halt Late-Stage Trial for Liver Cancer Therapy
-
RMB 240 Million! Wanhua Chemical Establishes Another Joint Venture in Binzhou
-
Advent Drops Its 2026 Purchase, and LANXESS’s €1.2 Billion Exit Plan Falls Through
-
End-of-Month Maleic Anhydride Market Trends Primarily Consolidating
-
Strong Demand Drives Slight Rise in Toluene Market in November
-
This Week's Acetic Acid Market Continues to Rise in China
-
China's Urea Market Fluctuates (11.21-11.28)
-
Premium Global Chemical Sourcing Requests (22-26 Dec 2025)